Insulin
Insulin is a pharmaceutical drug with 262 clinical trials. Currently 21 active trials ongoing. Historical success rate of 93.0%.
Success Metrics
Based on 172 completed trials
Phase Distribution
Phase Distribution
41
Early Stage
43
Mid Stage
96
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.6%
172 of 201 finished
14.4%
29 ended early
21
trials recruiting
262
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes
Gestational Diabetes and Pharmacotherapy (GAP)
Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults, Adolescents and Children on Top of Insulin Therapy (FABULINUS)
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
Clinical Trials (262)
Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes
Gestational Diabetes and Pharmacotherapy (GAP)
Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults, Adolescents and Children on Top of Insulin Therapy (FABULINUS)
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity
Antidiabetic Medications and Risk of Cancer
Triple Therapy in T1DM
Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin
A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)
Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
Effects of Cofrogliptin on Beta-Cell Function in LADA Patients
Intensive Versus Conventional Hyperglycemic Control in Hospitalized Non-critically Ill Patients
Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)
Regional Lipolysis Insulin Regulation
A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM
Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes
Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 262